P/E ratio for IDEXX Laboratories (IDXX)
P/E ratio as of September 2023 (TTM): 45.9
According to IDEXX Laboratories's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 45.8531. At the end of 2021 the company had a P/E ratio of 75.3.
P/E ratio history for IDEXX Laboratories from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 75.3 | 2.64% |
| 2020 | 73.4 | 39.42% |
| 2019 | 52.6 | 22.55% |
| 2018 | 43.0 | -17.58% |
| 2017 | 52.1 | 10.24% |
| 2016 | 47.3 | 34.56% |
| 2015 | 35.1 | -14.44% |
| 2014 | 41.1 | 36.3% |
| 2013 | 30.1 | 5.21% |
| 2012 | 28.6 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 29.8 | -35.05% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | 34.2 | -25.47% | 🇺🇸 USA |
 Henry Schein
HSIC | 21.5 | -53.06% | 🇺🇸 USA |
 Meridian Bioscience VIVO | 35.0 | -23.62% | 🇺🇸 USA |
 Neogen NEOG | -248 | -640.57% | 🇺🇸 USA |
 Heska Corporation
HSKA | -62.2 | -235.59% | 🇺🇸 USA |
 Petco WOOF | 30.1 | -34.41% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.